secwatch.observer — SEC 8-K summary
======================================

Issuer:     CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CIK:        0001187953
Form:       8-K
Filed at:   2021-09-22T23:59:59+00:00
Accession:  0001477932-21-006554
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Creative Medical enters direct employment with CEO, CFO, consultants; ends reimbursement agreement
--------------------------------------------------------------------------------

- CEO Timothy Warbington receives $330k annual base salary effective 9/16/2021.
- CFO Donald Dickerson receives $300k annual base salary effective 9/16/2021.
- Consultants Dr. Thomas Ichim and Dr. Amit Patel receive $120k and $240k per annum respectively.
- Prior Management Reimbursement Agreement with Creative Medical Health terminated 9/15/2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1187953/000147793221006554/0001477932-21-006554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1187953/000147793221006554/celz_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-21-006554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer